Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GoodRx Holdings (GDRX) Stock Price & Analysis
1,074 Followers
GDRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.14 - $9.37
Previous Close$7.19
Volume938.23K
Average Volume (3M)1.31M
Market Cap
$2.75B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)-307.3
Beta1.93
Next Earnings
May 09, 2024EPS Estimate
$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding394,997,372
10 Day Avg. Volume856,875
30 Day Avg. Volume1,313,233
Standard Deviation0.20
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)14.35
Price to Sales (P/S)0.89
Price to Cash Flow (P/CF)44.10
P/FCF Ratio27.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$8.88Price Target Upside23.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
GoodRx Holdings News
PremiumStock Analysis & Ideas
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
Bulls Say, Bears Say
Bulls Say
Company PerformanceGoodRx's consistent offering of the lowest prices, achieving the lowest price 83% of the time in a benchmark study, demonstrates its competitive edge in the discount platform market.
Revenue GrowthRecent survey data suggests ISP could be significant with up to $355M in revenue, indicating a strong potential increase compared to the current estimate.
Stock ValuationAnalyst maintains a price target of $12, based on DCF analysis, implying the shares have significant upside potential with an attractive valuation multiple.
Bears Say
Company StrategyStrategy pivots have lowered long-term growth visibility; limiting the ability to build a case for outperformance.
Competitive LandscapeCVS’ CostVantage plan and other competitive developments could have a dramatic impact on GoodRx’s model.
Financial PerformanceThe slight decrease in year-over-year Gold revenue despite increase in Gold membership suggests a mix shift toward less expensive plans.
---
Ownership Overview
36.76% Insiders
15.67% Mutual Funds
10.49% Other Institutional Investors
37.08% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $4.13 and its highest was $9.37 in the past 12 months.
What is GoodRx Holdings’s market cap?
Currently, no data Available
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is May 09, 2024 which is in 11 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Feb 29, 2024. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.068 by $0.012.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is $0.07.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 93,265,750 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, beating expectations of $0.068. Following the earnings report the stock price went up 20.402%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Among the largest hedge funds holding GoodRx Holdings’s share is Silver Lake Group, L.L.C.. It holds GoodRx Holdings’s shares valued at 24M.
---
GoodRx Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.88 (23.50% Upside)
$8.88 (23.50% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 7.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.9%
Last 30 Days ▲ 22.7%
Last 30 Days ▲ 22.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
47.94%
12-Months-Change
Fundamentals
Return on Equity
-1.12%
Trailing 12-Months
Asset Growth
-2.40%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.
---
GDRX Earnings Call
Q4 2024
0:00 / 0:00
---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Months Forecast
Average Price Target
$8.88
▲(23.50% Upside)
Technical Analysis
Best Analysts Covering GDRX
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+19.39%
reiterated a buy rating 2 months ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +19.39% per trade.
---